Point72 Hong Kong LTD Acadia Pharmaceuticals Inc Transaction History

Point72 Hong Kong LTD

$1.57 Billion
Q2 2024

A detailed history of Point72 Hong Kong LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Point72 Hong Kong LTD holds 28,054 shares of ACAD stock, worth $414,918. This represents 0.03% of its overall portfolio holdings.

Number of Shares

28,054

Previous 28,054 -0.0%

Holding current value

$414,918

Previous $518,000 12.16%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $296,612 - $514,528	16,673 Added 146.5%	28,054 $518,000
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $236,497 - $361,574	11,381 New	11,381 $356,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $218,698 - $457,568	16,810 Added 280.03%	22,813 $321,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $109,264 - $143,495	5,218 Added 664.71%	6,003 $145,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $116,891 - $188,600	-6,962 Reduced 89.87%	785 $18,000
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $27,472 - $43,124	-1,741 Reduced 18.35%	7,747 $129,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $28,226 - $39,896	1,455 Added 18.11%	9,488 $231,000
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $200,985 - $441,734	8,033 New	8,033 $207,000
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $474,406 - $742,482	-13,026 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $511,400 - $686,860	13,026 New	13,026 $631,000
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $9,336 - $13,826	-295 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $10,681 - $15,163	295 New	295 $13,000
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $46,790 - $78,319	-3,591 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $12,779 - $18,944	-848 Reduced 19.1%	3,591 $55,000
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $88,936 - $127,962	3,958 Added 822.87%	4,439 $100,000
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $11,568 - $16,869	431 Added 862.0%	481 $14,000
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $1,474 - $1,918	50	50 $2,000

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Account

Point72 Hong Kong LTD Acadia Pharmaceuticals Inc Transaction History